Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland

<p>Abstract</p> <p>Background</p> <p>Different radiation-techniques in treating local staged prostate cancer differ in their dose- distribution. Physical phantom measurements indicate that for 3D, less healthy tissue is exposed to a relatively higher dose compared to SS...

Full description

Bibliographic Details
Main Authors: Huber Peter E, Weber Klaus-Josef, Major Gerald, Sterzing Florian, Swartman Benedict, Zwicker Felix, Thieke Christian, Debus Jürgen, Herfarth Klaus
Format: Article
Language:English
Published: BMC 2011-06-01
Series:Radiation Oncology
Online Access:http://www.ro-journal.com/content/6/1/62
id doaj-2c266700f7f94e49984527d5a261c2db
record_format Article
spelling doaj-2c266700f7f94e49984527d5a261c2db2020-11-25T00:43:23ZengBMCRadiation Oncology1748-717X2011-06-01616210.1186/1748-717X-6-62Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate glandHuber Peter EWeber Klaus-JosefMajor GeraldSterzing FlorianSwartman BenedictZwicker FelixThieke ChristianDebus JürgenHerfarth Klaus<p>Abstract</p> <p>Background</p> <p>Different radiation-techniques in treating local staged prostate cancer differ in their dose- distribution. Physical phantom measurements indicate that for 3D, less healthy tissue is exposed to a relatively higher dose compared to SSIMRT. The purpose is to substantiate a dose distribution in lymphocytes <it>in-vivo </it>and to discuss the possibility of comparing it to the physical model of total body dose distribution.</p> <p>Methods</p> <p>For each technique (3D and SSIMRT), blood was taken from 20 patients before and 10 min after their first fraction of radiotherapy. The isolated leukocytes were fixed 2 hours after radiation. DNA double-strand breaks (DSB) in lymphocytes' nuclei were stained immunocytochemically using the gamma-H2AX protein. Gamma-H2AX foci inside each nucleus were counted in 300 irradiated as well as 50 non-irradiated lymphocytes per patient. In addition, lymphocytes of 5 volunteer subjects were irradiated externally at different doses and processed under same conditions as the patients' lymphocytes in order to generate a calibration-line. This calibration-line assigns dose-value to mean number of gamma-H2AX foci/ nucleus. So the dose distributions in patients' lymphocytes were determined regarding to the gamma-H2AX foci distribution. With this information a cumulative dose-lymphocyte-histogram (DLH) was generated. Visualized distribution of gamma-H2AX foci, correspondingly dose per nucleus, was compared to the technical dose-volume-histogram (DVH), related to the whole body-volume.</p> <p>Results</p> <p>Measured <it>in-vivo </it>(DLH) and according to the physical treatment-planning (DVH), more lymphocytes resulted with low-dose exposure (< 20% of the applied dose) and significantly fewer lymphocytes with middle-dose exposure (30%-60%) during Step-and-Shoot-IMRT, compared to conventional 3D conformal radiotherapy. The high-dose exposure (> 80%) was equal in both radiation techniques. The mean number of gamma-H2AX foci per lymphocyte was 0.49 (3D) and 0.47 (SSIMRT) without significant difference.</p> <p>Conclusions</p> <p><it>In-vivo </it>measurement of the dose distribution within patients' lymphocytes can be performed by detecting gamma-H2AX foci. In case of 3D and SSIMRT, the results of this method correlate with the physical calculated total body dose-distribution, but cannot be interpreted unrestrictedly due to the blood circulation. One possible application of the present method could be in radiation-protection for <it>in-vivo </it>dose estimation after accidental exposure to radiation.</p> http://www.ro-journal.com/content/6/1/62
collection DOAJ
language English
format Article
sources DOAJ
author Huber Peter E
Weber Klaus-Josef
Major Gerald
Sterzing Florian
Swartman Benedict
Zwicker Felix
Thieke Christian
Debus Jürgen
Herfarth Klaus
spellingShingle Huber Peter E
Weber Klaus-Josef
Major Gerald
Sterzing Florian
Swartman Benedict
Zwicker Felix
Thieke Christian
Debus Jürgen
Herfarth Klaus
Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
Radiation Oncology
author_facet Huber Peter E
Weber Klaus-Josef
Major Gerald
Sterzing Florian
Swartman Benedict
Zwicker Felix
Thieke Christian
Debus Jürgen
Herfarth Klaus
author_sort Huber Peter E
title Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
title_short Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
title_full Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
title_fullStr Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
title_full_unstemmed Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
title_sort biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-h2ax immunofluorescence staining: 3d conformal- vs. step-and-shoot imrt of the prostate gland
publisher BMC
series Radiation Oncology
issn 1748-717X
publishDate 2011-06-01
description <p>Abstract</p> <p>Background</p> <p>Different radiation-techniques in treating local staged prostate cancer differ in their dose- distribution. Physical phantom measurements indicate that for 3D, less healthy tissue is exposed to a relatively higher dose compared to SSIMRT. The purpose is to substantiate a dose distribution in lymphocytes <it>in-vivo </it>and to discuss the possibility of comparing it to the physical model of total body dose distribution.</p> <p>Methods</p> <p>For each technique (3D and SSIMRT), blood was taken from 20 patients before and 10 min after their first fraction of radiotherapy. The isolated leukocytes were fixed 2 hours after radiation. DNA double-strand breaks (DSB) in lymphocytes' nuclei were stained immunocytochemically using the gamma-H2AX protein. Gamma-H2AX foci inside each nucleus were counted in 300 irradiated as well as 50 non-irradiated lymphocytes per patient. In addition, lymphocytes of 5 volunteer subjects were irradiated externally at different doses and processed under same conditions as the patients' lymphocytes in order to generate a calibration-line. This calibration-line assigns dose-value to mean number of gamma-H2AX foci/ nucleus. So the dose distributions in patients' lymphocytes were determined regarding to the gamma-H2AX foci distribution. With this information a cumulative dose-lymphocyte-histogram (DLH) was generated. Visualized distribution of gamma-H2AX foci, correspondingly dose per nucleus, was compared to the technical dose-volume-histogram (DVH), related to the whole body-volume.</p> <p>Results</p> <p>Measured <it>in-vivo </it>(DLH) and according to the physical treatment-planning (DVH), more lymphocytes resulted with low-dose exposure (< 20% of the applied dose) and significantly fewer lymphocytes with middle-dose exposure (30%-60%) during Step-and-Shoot-IMRT, compared to conventional 3D conformal radiotherapy. The high-dose exposure (> 80%) was equal in both radiation techniques. The mean number of gamma-H2AX foci per lymphocyte was 0.49 (3D) and 0.47 (SSIMRT) without significant difference.</p> <p>Conclusions</p> <p><it>In-vivo </it>measurement of the dose distribution within patients' lymphocytes can be performed by detecting gamma-H2AX foci. In case of 3D and SSIMRT, the results of this method correlate with the physical calculated total body dose-distribution, but cannot be interpreted unrestrictedly due to the blood circulation. One possible application of the present method could be in radiation-protection for <it>in-vivo </it>dose estimation after accidental exposure to radiation.</p>
url http://www.ro-journal.com/content/6/1/62
work_keys_str_mv AT huberpetere biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT weberklausjosef biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT majorgerald biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT sterzingflorian biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT swartmanbenedict biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT zwickerfelix biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT thiekechristian biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT debusjurgen biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
AT herfarthklaus biologicalinvivomeasurementofdosedistributioninpatientslymphocytesbygammah2aximmunofluorescencestaining3dconformalvsstepandshootimrtoftheprostategland
_version_ 1725278697801383936